These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 6621756

  • 1. Lack of evidence for a role for prostaglandins in the mediation of impaired urinary concentrating ability in Bartter's syndrome.
    Chan JC, Gill JR, Bartter FC.
    Nephron; 1983; 35(2):116-9. PubMed ID: 6621756
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacologic studies in Bartter's syndrome: effect of DDAVP and indomethacin on renal concentrating operation. Part II.
    Radó JP, Simatupang T, Boer P, Dorhout Mees EJ.
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):22-6. PubMed ID: 631967
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
    Bowden RE, Gill JR, Radfar N, Taylor AA, Keiser HR.
    JAMA; 1978 Jan 09; 239(2):117-21. PubMed ID: 412983
    [Abstract] [Full Text] [Related]

  • 6. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
    Gill JR, Frölich JC, Bowden RE, Taylor AA, Keiser HR, Seyberth HW, Oates JA, Bartter FC.
    Am J Med; 1976 Jul 09; 61(1):43-51. PubMed ID: 820194
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Does defective chloride reabsorption at the loop of Henle play a major role in the pathogenesis of Bartter's syndrome?
    Milani L, Pessina AC, Maccà F, Pauletto P, Gatta A.
    Am J Nephrol; 1987 Jul 09; 7(1):65-8. PubMed ID: 3578377
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ, de Jong PE, van Eps LW, Brentjens JR, Bakker K, Doorenbos H.
    Nephron; 1977 Jul 09; 19(4):200-13. PubMed ID: 917167
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Asymptomatic Bartter's syndrome.
    Barbour GL, Day JO.
    South Med J; 1978 Nov 09; 71(11):1341-4, 1349. PubMed ID: 715482
    [Abstract] [Full Text] [Related]

  • 15. Role of prostaglandins in the pathogenesis of Bartter's syndrome.
    Fichman MP, Telfer N, Zia P, Speckart P, Golub M, Rude R.
    Am J Med; 1976 May 31; 60(6):785-97. PubMed ID: 798488
    [Abstract] [Full Text] [Related]

  • 16. Bartter's syndrome--observations on the pathophysiology.
    Solomon LR, Bobinski H, Astley P, Goldby FS, Mallick NP.
    Q J Med; 1982 May 31; 51(203):251-70. PubMed ID: 7146310
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.